Tianjin Tianyao Pharmaceutical Competitors and Similar CompaniesClear all

Tianjin Tianyao Pharmaceutical's competitors and similar companies include Octapharma, Akums Drugs and Pharmaceuticals, Bausch Health Americas and Patheon.

	Tianjin Tianyao Pharmaceutical Tianjin Tianyao Pharmaceutical (天津天药药业股份有限公司) is a company that manufactures injection products.	Octapharma Octapharma is one of the largest human protein manufacturers, developing and producing human proteins from human plasma and human cell lines.	Akums Drugs and Pharmaceuticals Akums Drugs and Pharmaceuticals is a contract development and manufacturing organization (CDMO).	Bausch Health Americas Bausch Health Americas (BHA) is a pharmaceutical preparation manufacturing company.	Patheon Patheon is a company that provides commercial manufacturing and pharmaceutical development services.
Founding Date	Founding Date 1939	Founding Date 1983	Founding Date 2004	Founding Date 1994	Founding Date 2014
Type	Type Public	Type Private	Type Private	Type Subsidiary	Type Subsidiary
Tags	Tags Manufacturing & Industrial drug development pharma	Tags Manufacturing & Industrial drug development pharma	Tags Healthcare drug development pharma	Tags Manufacturing & Industrial drug development pharma	Tags Manufacturing & Industrial drug development pharma
Locations	Locations CN HQ	Locations Lachen, CH HQ Pyrmont, AU Wien, AT Baku, AZ Minsk, BY Anderlecht, BE see more	Locations Delhi, IN HQ Delhi, IN	Locations Bridgewater, US HQ Laval, CA Steinbach, CA Envigado, CO La Estrella, CO Medellín, CO Ciudad De México, MX see more	Locations Mississauga, CA HQ
Employees	Employees 2,884	Employees 12,000	Employees 4,4829% increase	Employees 4,044	Employees 6,500
Financial
Revenue (est.)	Revenue (est.) ¥3.1b (FY, 2024)	Revenue (est.) €2.5b (FY, 2021)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods ¥1.8b (FY, 2024)	Cost of goods €1.7b (FY, 2021)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit ¥1.4b (FY, 2024)	Gross profit €808.2m (FY, 2021)	Gross profit N/A	Gross profit N/A	Gross profit N/A
Net income	Net income ¥208.2m (FY, 2024)	Net income €438.3m (FY, 2021)	Net income N/A	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 70m	Total funding raised N/A	Total funding raised $ 150m